Subthalamic stimulation in Parkinson's disease. Preliminary results

Area of Science:

• Neurosurgery
• Neurology
• Medical Technology

Background:

• Parkinson's disease (PD) significantly impacts motor function and daily living.
• Severe PD often involves medically refractory symptoms like drug-induced dyskinesia.
• Pallidotomy has been a surgical option, but alternatives are sought.

Purpose of the Study:

• To evaluate chronic subthalamic nucleus (STN) stimulation as an alternative to pallidotomy.
• To assess the efficacy of STN deep brain stimulation (DBS) for severe Parkinson's disease.
• To compare STN DBS with pallidotomy for symptom management.

Main Methods:

• A comparative study involving patients with severe, medically refractory Parkinson's disease.
• Three patients underwent stereotactic implantation of deep brain stimulators (DBS) targeting the STN.
• The control group received unilateral pallidotomy.
• Pre- and postoperative assessments included video analysis, neuropsychometric testing, and clinical staging.

Main Results:

• At a mean 6-month follow-up, STN DBS demonstrated significant improvements in motor scores.
• Patients receiving STN DBS showed marked improvements in activities of daily living.
• A reduction of approximately 50% in daily levodopa intake was observed within 3 months of stimulation.

Conclusions:

• Chronic STN stimulation is a viable and effective treatment for severe Parkinson's disease.
• STN deep brain stimulation (DBS) provides greater motor benefits compared to pallidotomy.
• STN DBS offers a promising alternative for managing advanced Parkinson's disease symptoms.